Navigation Links
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in Incyte Corporation of Class Action Lawsuit and the May 6, 2013 Lead Plaintiff Deadline
Date:4/23/2013

NEW YORK, April 23, 2013 /PRNewswire/ -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Delaware on behalf of investors who purchased Incyte Corporation ("Incyte" or the "Company") (NasdaqGS: INCY) stock between April 26, 2012 and August 1, 2012 (the "Class Period").

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )

For more information, click here: http://zlk.9nl.com/incyte-incy/.  

According to the complaint, Incyte's reported fourth quarter 2011 and first quarter 2012 sales were artificially inflated due to a large number of advanced-stage myelofibrosis patients being prescribed the drug upon FDA approval in November 2011--patients who had been too sick to participate in the clinical trials.

On August 2, 2012, Incyte disclosed that Jakafi sales growth had been much softer during the second quarter of 2012 than investors had been led to expect. Defendants also disclosed that many of the new patients prescribed Jakafi were so sick they would not have been eligible for the Phase III trial. Defendants conceded that while prescriptions to these patients had increased sales revenues, these were not revenues that would continue for the suggested three years on average that defendants claimed, as certain patients died. In response to these disclosures, the price of Incyte stock fell from its August 1, 2012 close of $24.92 per share to close at $19.57 per share on August 2, 2012.

If you suffered a loss in Incyte you have until May 6, 2013 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph
'/>"/>

SOURCE Levi & Korsinsky, LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
2. ICBS, Update for Shareholders.
3. NeoStems CEO Letter to Shareholders
4. Monsanto Attempts to Lockout Socially Responsible Shareholder at Annual Meeting
5. SPO Updates Shareholders on 2012 Corporate Strategy
6. SeraCare Shareholders Approve Acquisition by Linden Capital Partners
7. Genesis Biopharma Issues Letter To Shareholders
8. Medical Marijuana Inc. Shareholder Update - PhytoSPHERE Systems, LLC
9. Amarantus BioSciences Updates Shareholders on Timing of Michael J. Fox Foundation Grant Data Release
10. Correction: Amarantus BioSciences Updates Shareholders on Timing of Michael J. Fox Foundation Grant Data Release
11. Amarantus BioSciences Issues CEO Letter to Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Calif. , Oct. 30, 2014  Ardelyx, ... biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic ... quarter 2014 financial results on Thursday, November 6, ... will host a live conference call and webcast ... results and provide a business update. ...
(Date:10/30/2014)... 2014 SoundConnect , an ... Office 365 end users the key to turning ... system by adding voice enablement and hybrid audio ... Online, a communication tool that includes presence, instant ... voice, O365 becomes a comprehensive unified communications solution. ...
(Date:10/30/2014)... New York, NY (PRWEB) October 30, 2014 ... investment plan for its ICH Stability Testing and Package ... companies, this investment centers on a dramatic increase in ... larger volume of stability, storage and aging samples to ... first stage of this major capital expenditure has already ...
(Date:10/30/2014)... -- A new report, commissioned by BioCrossroads and conducted ... look at Indiana,s capital market ... different time frames: 1993 to 2002 and 2003 to ... for investment growth.  The Life Science Innovation Capital ... in innovation dollars as well as an increase in ...
Breaking Biology Technology:Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014 2SoundConnect Launches Voice Enablement and Hybrid Audio Conferencing for Office 365 2SoundConnect Launches Voice Enablement and Hybrid Audio Conferencing for Office 365 3Whitehouse Labs Announces Major Capital Investment in Stability and Storage Testing Capacity 2Whitehouse Labs Announces Major Capital Investment in Stability and Storage Testing Capacity 3New report shows Indiana's gains in life sciences innovation capital outpace the nation 2New report shows Indiana's gains in life sciences innovation capital outpace the nation 3New report shows Indiana's gains in life sciences innovation capital outpace the nation 4New report shows Indiana's gains in life sciences innovation capital outpace the nation 5
... 14 Bionovo, Inc.,(Nasdaq: BNVI ) announced ... Board of Directors. Mr. Drapeau has extensive financial,management ... "We are quite excited to have access to ... CEO. "Lou is particularly well versed,in the unique ...
... CALGARY, March 14 /PRNewswire-FirstCall/ - SemBioSys Genetics ... portfolio of therapeutic,proteins for metabolic and cardiovascular ... an important step forward in the,commercialization of ... an,exclusive global alliance with Bioriginal Food and ...
... Express, the advance online publication of the journal ... mark an important step toward understanding a longstanding ... presented their findings at the annual meeting of ... problem the physicists addressed is how a fundamental ...
Cached Biology Technology:Louis Drapeau Joins Bionovo's Board of Directors 2Louis Drapeau Joins Bionovo's Board of Directors 3SemBioSys' GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil 2SemBioSys' GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil 3Physicists discover how fundamental particles lose track of quantum mechanical properties 2Physicists discover how fundamental particles lose track of quantum mechanical properties 3
(Date:10/31/2014)... Geologists are letting the air out of a nagging mystery ... have long speculated as to why animal species didn,t flourish ... to prosper at the end of the Proterozoic period, about ... stretch before that, when most researchers think there also was ... so great then, after all. , In a study published ...
(Date:10/31/2014)... has just been cleared – by a mouse. ... Chapel Hill and colleagues have developed the first genetic ... and display symptoms similar to those that humans experience. ... Science , will significantly improve basic research on Ebola ... the worldwide public health and economic toll of the ...
(Date:10/31/2014)... have been studying the behavior of approximately 300 ... years. They observed that ravens slowly build alliances ... However, they also observed that these affiliative interactions ... in about 50 % of the cases these ... affiliating ravens, intervening can be potentially risky when ...
Breaking Biology News(10 mins):Lack of oxygen delayed the rise of animals on Earth 2Improved mouse model will accelerate research on potential Ebola vaccines, treatments 2
... is available in German . , Metabolomics aims ... cell or a tissue. The exponents of bioinformatics analyzed data ... healthy and diabetic mice. In each case, a subgroup of ... more than 800 metabolites were quantitatively determined in a blood ...
... flower and plant growers know all too well that ... and deterring healthy growth of potted ornamental plants. To ... expensive practice of paying workers to hand-weed containers. Some ... on the wide range of plant species produced in ...
... July/August 2008 issue of BioScience are as follows: ... Joan Burnside, and Scott V. Edwards. , An increasingly broad ... expanding what has been learned from studies based on the ... of the whole class. ***************, Penguins as Marine ...
Cached Biology News:Healthy or diseased? 2Ethanol byproduct produces green results 2BioScience tip sheet July/August 2008 2BioScience tip sheet July/August 2008 3
... amino acid synthetic peptide whose sequences are derived from mouse resistin ... terminus): S(21) - S - M - P - L - ... - I - D - K - K - I - ... may be used for neutralization and control experiments with the polyclonal ...
... 2D Proteomic Imaging System, Basic Package ... Wide Dynamic Range: The ProXPRESS 2D Proteomic ... imaging system for both proteomic and general ... unparalleled flexibility, enabling the use of all ...
... designed for quantitative assays using recombinant ... on the flexible and powerful Paraflo ... specified sequences can be synthesized on-chip ... with custom sequence design. These microarrays ...
... These extended-length microarrays are custom designed to ... configurations are available: 8,455 features per array ... 22,575 features per array (1 array/slide). ... probe length - This extended length ...
Biology Products: